
Oncolytics Biotech Inc.
ONCYHealthcare|Biotechnology|US
$0.44
-0.01 (-2.09%)
DCF Value
$0.02
Cash / Share
$0.03
Ownership Breakdown
116.5%
Float
100.4M
Shares Outstanding
116.9M
Float Shares
Major Holders (6)
Combined: 42.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Anson Funds Management LP | IA, PN | 7.00% | 7,649,050 | Nov 14, 2025 | 13D/G |
| Anson Management GP LLC | HC, OO | 7.00% | 7,649,050 | Nov 14, 2025 | 13D/G |
| Tony Moore | HC, IN | 7.00% | 7,649,050 | Nov 14, 2025 | 13D/G |
| Anson Advisors Inc. | FI, CO | 7.00% | 7,649,050 | Nov 14, 2025 | 13D/G |
| Amin Nathoo | HC, IN | 7.00% | 7,649,050 | Nov 14, 2025 | 13D/G |
| Moez Kassam | HC, IN | 7.00% | 7,649,050 | Nov 14, 2025 | 13D/G |
Insider Trades (89)
Last 4 quarters: 404,282 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| McAdory John Bearden | Chief Operating Officer | Jun 1, 2026 | OTHER | 500,000 | $0.97 | $485.0K | Form 4 |
| Glover Stephen C. | director: | Jun 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Parsons James T. | director | Mar 11, 2026 | BUY | 10,000 | $1.03 | $10.3K | Form 4 |
| Kelly Jared | director, officer: Chief Executive Officer | Mar 12, 2026 | BUY | 5,050 | $0.96 | $4.8K | Form 4 |
| Kelly Jared | director, officer: Chief Executive Officer | Feb 12, 2026 | BUY | 29,500 | $0.84 | $24.8K | Form 4 |
| Kelly Jared | director, officer: Chief Executive Officer | Feb 11, 2026 | BUY | 5,600 | $0.84 | $4.7K | Form 4 |
| Look Kirk | Chief Financial Officer | Feb 12, 2026 | BUY | 12,000 | $0.84 | $10.1K | Form 4 |
| Pisano Wayne | director | Feb 12, 2026 | BUY | 30,000 | $0.84 | $25.3K | Form 4 |
| Heineman Thomas Charles | Chief Medical Officer | Feb 12, 2026 | BUY | 12,132 | $0.83 | $10.0K | Form 4 |
| Brown Deborah Margaret | director | Feb 12, 2026 | BUY | 25,000 | $0.85 | $21.2K | Form 4 |
| Hagerman Allison | VP, Product Development | Feb 12, 2026 | BUY | 10,000 | $0.83 | $8.3K | Form 4 |
| Seizinger Bernd R. | director | Feb 12, 2026 | BUY | 40,000 | $0.85 | $33.9K | Form 4 |
| Seizinger Bernd R. | director | Feb 11, 2026 | BUY | 60,000 | $0.83 | $49.6K | Form 4 |
| Aromando Andrew | Chief Business Officer | Feb 11, 2026 | BUY | 29,600 | $0.86 | $25.4K | Form 4 |
| Andrews Patricia S | director | Feb 12, 2026 | BUY | 35,400 | $0.86 | $30.3K | Form 4 |
| Seizinger Bernd R. | director | Jan 16, 2026 | BUY | 100,000 | $1.04 | $103.8K | Form 4 |
| Look Kirk | Chief Financial Officer | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Look Kirk | Chief Financial Officer | Jan 1, 2026 | OTHER | 31,578 | $2.66 | $84.0K | Form 4 |
| Look Kirk | Chief Financial Officer | Jan 1, 2026 | OTHER | 155,000 | $3.40 | $527.0K | Form 4 |
| Look Kirk | Chief Financial Officer | Jan 1, 2026 | OTHER | 80,000 | $2.31 | $184.8K | Form 4 |
| Look Kirk | Chief Financial Officer | Jan 1, 2026 | OTHER | 105,000 | $2.76 | $289.8K | Form 4 |
| Look Kirk | Chief Financial Officer | Jan 1, 2026 | OTHER | 231,700 | $1.91 | $442.5K | Form 4 |
| Look Kirk | Chief Financial Officer | Jan 1, 2026 | OTHER | 250,000 | $0.99 | $247.5K | Form 4 |
| Look Kirk | Chief Financial Officer | Jan 1, 2026 | OTHER | 243,600 | $1.13 | $275.3K | Form 4 |
| Look Kirk | Chief Financial Officer | Jan 1, 2026 | OTHER | 570,000 | $1.08 | $615.6K | Form 4 |
| Andrews Patricia S | director | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Andrews Patricia S | director | Jan 1, 2026 | OTHER | 45,000 | $1.76 | $79.2K | Form 4 |
| Andrews Patricia S | director | Jan 1, 2026 | OTHER | 30,000 | $1.08 | $32.4K | Form 4 |
| Kelly Jared | director, officer: Chief Executive Officer | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Kelly Jared | director, officer: Chief Executive Officer | Jan 1, 2026 | OTHER | 450,000 | $1.08 | $486.0K | Form 4 |
| Kelly Jared | director, officer: Chief Executive Officer | Jan 1, 2026 | OTHER | 350,000 | $0.99 | $346.5K | Form 4 |
| Kelly Jared | director, officer: Chief Executive Officer | Jan 1, 2026 | OTHER | 2,850,000 | $0.57 | $1.6M | Form 4 |
| Hagerman Allison | VP, Product Development | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Hagerman Allison | VP, Product Development | Jan 1, 2026 | OTHER | 80,000 | $2.31 | $184.8K | Form 4 |
| Hagerman Allison | VP, Product Development | Jan 1, 2026 | OTHER | 21,700 | $2.76 | $59.9K | Form 4 |
| Hagerman Allison | VP, Product Development | Jan 1, 2026 | OTHER | 72,800 | $1.91 | $139.0K | Form 4 |
| Hagerman Allison | VP, Product Development | Jan 1, 2026 | OTHER | 75,600 | $1.13 | $85.4K | Form 4 |
| Hagerman Allison | VP, Product Development | Jan 1, 2026 | OTHER | 7,894 | $2.66 | $21.0K | Form 4 |
| Hagerman Allison | VP, Product Development | Jan 1, 2026 | OTHER | 45,000 | $3.40 | $153.0K | Form 4 |
| Hagerman Allison | VP, Product Development | Jan 1, 2026 | OTHER | 240,000 | $1.08 | $259.2K | Form 4 |
| Hagerman Allison | VP, Product Development | Jan 1, 2026 | OTHER | 250,000 | $0.99 | $247.5K | Form 4 |
| Heineman Thomas Charles | Chief Medical Officer | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Heineman Thomas Charles | Chief Medical Officer | Jan 1, 2026 | OTHER | 570,000 | $1.08 | $615.6K | Form 4 |
| Heineman Thomas Charles | Chief Medical Officer | Jan 1, 2026 | OTHER | 250,000 | $0.99 | $247.5K | Form 4 |
| Heineman Thomas Charles | Chief Medical Officer | Jan 1, 2026 | OTHER | 120,000 | $3.40 | $408.0K | Form 4 |
| Heineman Thomas Charles | Chief Medical Officer | Jan 1, 2026 | OTHER | 231,700 | $1.91 | $442.5K | Form 4 |
| Heineman Thomas Charles | Chief Medical Officer | Jan 1, 2026 | OTHER | 88,900 | $2.76 | $245.4K | Form 4 |
| Heineman Thomas Charles | Chief Medical Officer | Jan 1, 2026 | OTHER | 243,600 | $1.13 | $275.3K | Form 4 |
| Heineman Thomas Charles | Chief Medical Officer | Jan 1, 2026 | OTHER | 80,000 | $2.31 | $184.8K | Form 4 |
| Holtham Angela | director | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Holtham Angela | director | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Holtham Angela | director | Jan 1, 2026 | OTHER | 30,000 | $1.08 | $32.4K | Form 4 |
| Holtham Angela | director | Jan 1, 2026 | OTHER | 30,000 | $2.76 | $82.8K | Form 4 |
| Holtham Angela | director | Jan 1, 2026 | OTHER | 30,000 | $1.13 | $33.9K | Form 4 |
| Holtham Angela | director | Jan 1, 2026 | OTHER | 30,000 | $3.40 | $102.0K | Form 4 |
| Holtham Angela | director | Jan 1, 2026 | OTHER | 30,000 | $1.14 | $34.2K | Form 4 |
| Parsons James T. | director | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Parsons James T. | director | Jan 1, 2026 | OTHER | 30,000 | $1.13 | $33.9K | Form 4 |
| Parsons James T. | director | Jan 1, 2026 | OTHER | 30,000 | $1.08 | $32.4K | Form 4 |
| Parsons James T. | director | Jan 1, 2026 | OTHER | 30,000 | $2.76 | $82.8K | Form 4 |
| Parsons James T. | director | Jan 1, 2026 | OTHER | 45,000 | $1.14 | $51.3K | Form 4 |
| Seizinger Bernd R. | director | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Seizinger Bernd R. | director | Jan 1, 2026 | OTHER | 30,000 | $1.14 | $34.2K | Form 4 |
| Seizinger Bernd R. | director | Jan 1, 2026 | OTHER | 30,000 | $3.40 | $102.0K | Form 4 |
| Seizinger Bernd R. | director | Jan 1, 2026 | OTHER | 30,000 | $2.76 | $82.8K | Form 4 |
| Seizinger Bernd R. | director | Jan 1, 2026 | OTHER | 30,000 | $1.13 | $33.9K | Form 4 |
| Seizinger Bernd R. | director | Jan 1, 2026 | OTHER | 30,000 | $1.08 | $32.4K | Form 4 |
| Pisano Wayne | director | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Pisano Wayne | director | Jan 1, 2026 | OTHER | 37,500 | $1.13 | $42.4K | Form 4 |
| Pisano Wayne | director | Jan 1, 2026 | OTHER | 37,500 | $1.14 | $42.7K | Form 4 |
| Pisano Wayne | director | Jan 1, 2026 | OTHER | 37,500 | $1.08 | $40.5K | Form 4 |
| Pisano Wayne | director | Jan 1, 2026 | OTHER | 37,500 | $2.76 | $103.5K | Form 4 |
| Pisano Wayne | director | Jan 1, 2026 | OTHER | 37,500 | $3.40 | $127.5K | Form 4 |
| Brown Deborah Margaret | director | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Brown Deborah Margaret | director | Jan 1, 2026 | OTHER | 30,000 | $3.40 | $102.0K | Form 4 |
| Brown Deborah Margaret | director | Jan 1, 2026 | OTHER | 30,000 | $1.13 | $33.9K | Form 4 |
| Brown Deborah Margaret | director | Jan 1, 2026 | OTHER | 30,000 | $2.76 | $82.8K | Form 4 |
| Brown Deborah Margaret | director | Jan 1, 2026 | OTHER | 30,000 | $1.14 | $34.2K | Form 4 |
| Brown Deborah Margaret | director | Jan 1, 2026 | OTHER | 30,000 | $1.08 | $32.4K | Form 4 |
| Brown Deborah Margaret | director | Jan 1, 2026 | OTHER | 5,263 | $5.42 | $28.5K | Form 4 |
| Aromando Andrew | Chief Business Officer | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Aromando Andrew | Chief Business Officer | Jan 1, 2026 | OTHER | 300,000 | $1.08 | $324.0K | Form 4 |
| Aromando Andrew | Chief Business Officer | Jan 1, 2026 | OTHER | 750,000 | $0.93 | $697.5K | Form 4 |
| Aromando Andrew | Chief Business Officer | Jan 1, 2026 | OTHER | 250,000 | $0.99 | $247.5K | Form 4 |
| RIGBY JONATHAN | director | Jan 1, 2026 | OTHER | 0 | — | — | Form 4 |
| RIGBY JONATHAN | director | Jan 1, 2026 | OTHER | 30,000 | $1.08 | $32.4K | Form 4 |
| RIGBY JONATHAN | director | Jan 1, 2026 | OTHER | 30,000 | $2.76 | $82.8K | Form 4 |
| RIGBY JONATHAN | director | Jan 1, 2026 | OTHER | 30,000 | $1.13 | $33.9K | Form 4 |
| RIGBY JONATHAN | director | Jan 1, 2026 | OTHER | 45,000 | $1.84 | $82.8K | Form 4 |